Skip to content

Study on the effect and mechanism of low-dose esketamine on postoperative cognition of elderly patients

Study on the effect and mechanism of low-dose esketamine on postoperative cognition of elderly patients

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100042227
Enrollment
Unknown
Registered
2021-01-16
Start date
2021-06-01
Completion date
Unknown
Last updated
2021-04-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative cognition

Interventions

group A: esketamine0.125mg/kg
group B:esketamine0.25mg/kg

Sponsors

The First Affiliated Hospital of Nanchang University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Patients who plan to receive elective surgery for gastrointestinal tumors; 2. Subjects over 65 years old, regardless of gender; 3. Subjects with ASA grade I - III; 4. Subjects with operation time more than 2 hours; 5. Those subjects who have a detailed understanding of the nature, significance and possible benefits of the trial before the trial, the possible inconvenience and potential risks, understand the research procedures and sign the informed consent voluntarily in writing.

Exclusion criteria

Exclusion criteria: 1. Subjects who are allergic to the active ingredients of esmketamine or the narcotic drugs used; 2. Patients with serious risk of elevated blood pressure or intracranial pressure; 3. Patients with poorly controlled or untreated hypertension (arterial hypertension, resting systolic / diastolic blood pressure over 180 / 100mmhg); 4. Patients with hyperthyroidism without treatment or insufficient treatment; 5. Subjects with central nervous system diseases (such as Alzheimer's disease); 6. Subjects taking sedatives or antidepressants; 7. Subjects with alcohol or drug dependence; 8. Subjects unable to complete the neurocognitive function test; 9. Subjects with severe visual, auditory or communication impairment; 10. Subjects with a history of cerebrovascular accident within three years; 11. Subjects with MMSE < 23 before operation; 12. Subjects who are unable to communicate effectively with the researchers or who are considered unsuitable by the researchers.

Design outcomes

Primary

MeasureTime frame
postoperation cognitive score;

Secondary

MeasureTime frame
CRP;S-100ß protein;

Countries

China

Contacts

Public ContactWang Xiuhong

The First Affiliated Hospital of Nanchang University

405440892@qq.com+86 15979166716

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026